Drugs / TENIFATECAN
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00385177 | Sep 2006 → Dec 2008 | breast neoplasm, colorectal neoplasm, lung neoplasm, pancreatic neoplasm | Achieve Life Sciences | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TENIFATECAN | ChEMBL registry synonym — accepted as the source's own label CHEMBL2105666 ↗ |
| Known as | SN2310 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00385177 ↗ |
| Modality | Small molecule | — CHEMBL2105666 ↗ |
| Route | Intravenous | “administered intravenously” NCT00385177 ↗ |